Progressive Multifocal Leukoencephalopathy
En Español (Spanish Version)

Definition
PML is a rare progressive disease of the nervous system. It is caused by a viral infection of the cells that produce myelin.

The Neuron

Copyright © Nucleus Medical Media, Inc.

Causes
PML is caused by a specific papovavirus, known as JC virus. Many people get this infection in childhood. It produces no illness and generally does not infect the nervous system. It reactivates later in life in people who have suppressed immune systems. The virus damages oligodendrocytes, the cells in the central nervous system (CNS) which produce myelin, the material that wraps around nerves. This impairs nerve function.

Risk Factors
PML is most common in people with suppressed immune systems. Suppressed immune systems may be the result of:

  • HIV/AIDS (most common)
  • Leukemia and lymphoma
  • Organ transplant
  • Cancer
  • Chronic steroid therapy
  • Rare inherited immunodeficiencies
  • Certain medications, such as natalizumab, a medication used to treat multiple sclerosis (MS)
Symptoms
Symptoms progress over weeks and may include:

  • Vision problems
  • Speech pronunciation problems
  • Coordination loss
  • Memory loss
  • Weakness in limbs
  • Behavioral changes
  • Changes in thinking
  • A loss of language capability—aphasia
  • Seizures
  • Sensory loss
Diagnosis
Your doctor will ask about your symptoms and medical history. A physical exam will be done. Tests may include:

  • MRI scan—used to take images of brain structures (key in the diagnosis)
  • Lumbar puncture—to evaluate cerebrospinal fluid
  • Blood and urine tests
  • Brain biopsy
Treatment
Treatment focuses on strategies to improve the immune system. If you have HIV, your doctor will most likely prescribe antiretroviral medications to treat this condition. If PML has resulted from the drug natalizumab, your doctor will have you stop taking this drug and may recommend a plasma exchange to remove the drug from your blood system.

Prevention
There are no current guidelines to prevent exposure to the JC virus. If you have a suppressed immune system, get treatment to minimize your risk.




RESOURCES:
AIDS Information, Education, Action, Awareness

National Organization for Rare Disorders

CANADIAN RESOURCES:
Canadian AIDS Society

Canadian Organization for Rare Disorders

References:
Progressive multifocal leukoencephalopathy (PML). AETC National Resource Center website. Available at: http://aidsetc.org/resource/progressive-multifocal-leukoencephalopathy-pml. Updated May 1, 2013. Accessed June 2, 2014.

NINDS Progressive multifocal leukoencephalopathy information page. National Institute of Neurological Disorders and Stroke website. Available at http://www.ninds.nih.gov/disorders/pml/pml.htm. Updated February 14, 2014. Accessed June 2, 2014.

Progressive multifocal leukoencephalopathy. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated October 1, 2013. Accessed June 2, 2014.

Warnke C, Menge T, Hartung HP, et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol. 2010;67(8):923-30.

Last Reviewed May 2014



Health Information Library content is provided by EBSCO Publishing, fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.

 

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

 

To send comments or feedback to EBSCO's Editorial Team regarding the content please e-mail healthlibrarysupport@ebscohost.com.